1. Product Overview
2.
Research Methodology
3. Executive Summary
4.
Impact of COVID-19 on Global CAR-T Cell Therapy Market
5. Voice of Customers
5.1. Brand Awareness
5.2. Unmet Need and Challenges
5.3. Factors Driving the CAR-T Cell Therapy Market
6. Global CAR-T Cell
Therapy Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel),
Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel),
Abecma (Idecabtagene Vicleucel), Others)
6.2.2. By Tumor Type (Hematological Malignancies, Solid
Tumors)
6.2.3. By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute
Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma
(MCL), Others)
6.2.4. By Treatment Type (Single Treatment, Combination Treatment)
6.2.5. By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others)
6.2.6. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers,
Others)
6.2.7. By Region
6.2.8. By Company
6.3. Market Map
7. North America CAR-T
Cell Therapy Market Outlook, 2016-2026F
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Tumor Type
7.2.3. By Indication
7.2.4. By Treatment Type
7.2.5. By Targeted Antigen
7.2.6. By End User
7.2.7. By Country
7.3.
North America: Country Analysis
7.3.1. United States CAR-T
Cell Therapy Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product Type
7.3.1.2.2.
By Tumor Type
7.3.1.2.3.
By Indication
7.3.1.2.4.
By Treatment Type
7.3.1.2.5.
By Targeted Antigen
7.3.1.2.6.
By End User
7.3.2. Canada CAR-T Cell
Therapy Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product Type
7.3.2.2.2.
By Tumor Type
7.3.2.2.3.
By Indication
7.3.2.2.4.
By Treatment Type
7.3.2.2.5.
By Targeted Antigen
7.3.2.2.6.
By End User
7.3.3. Mexico CAR-T Cell
Therapy Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product Type
7.3.3.2.2.
By Tumor Type
7.3.3.2.3.
By Indication
7.3.3.2.4.
By Treatment Type
7.3.3.2.5.
By Targeted Antigen
7.3.3.2.6.
By End User
8. Europe CAR-T Cell
Therapy Market Outlook, 2016-2026F
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Tumor Type
8.2.3. By Indication
8.2.4. By Treatment Type
8.2.5. By Targeted Antigen
8.2.6. By End User
8.2.7. By Country
8.3.
Europe: Country Analysis
8.3.1. Germany CAR-T Cell
Therapy Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product Type
8.3.1.2.2.
By Tumor Type
8.3.1.2.3.
By Indication
8.3.1.2.4.
By Treatment Type
8.3.1.2.5.
By Targeted Antigen
8.3.1.2.6.
By End User
8.3.2. France CAR-T Cell
Therapy Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product Type
8.3.2.2.2.
By Tumor Type
8.3.2.2.3.
By Indication
8.3.2.2.4.
By Treatment Type
8.3.2.2.5.
By Targeted Antigen
8.3.2.2.6.
By End User
8.3.3. Switzerland CAR-T
Cell Therapy Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product Type
8.3.3.2.2.
By Tumor Type
8.3.3.2.3.
By Indication
8.3.3.2.4.
By Treatment Type
8.3.3.2.5.
By Targeted Antigen
8.3.3.2.6.
By End User
8.3.4. United Kingdom CAR-T
Cell Therapy Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product Type
8.3.4.2.2.
By Tumor Type
8.3.4.2.3.
By Indication
8.3.4.2.4.
By Treatment Type
8.3.4.2.5.
By Targeted Antigen
8.3.4.2.6.
By End User
8.3.5. Italy CAR-T Cell
Therapy Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product Type
8.3.5.2.2.
By Tumor Type
8.3.5.2.3.
By Indication
8.3.5.2.4.
By Treatment Type
8.3.5.2.5.
By Targeted Antigen
8.3.5.2.6.
By End User
8.3.6. Spain CAR-T Cell
Therapy Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Product Type
8.3.6.2.2.
By Tumor Type
8.3.6.2.3.
By Indication
8.3.6.2.4.
By Treatment Type
8.3.6.2.5.
By Targeted Antigen
8.3.6.2.6.
By End User
9. Asia-Pacific CAR-T
Cell Therapy Market Outlook, 2016-2026F
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Tumor Type
9.2.3. By Indication
9.2.4. By Treatment Type
9.2.5. By Targeted Antigen
9.2.6. By End User
9.2.7. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. China CAR-T Cell
Therapy Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product Type
9.3.1.2.2.
By Tumor Type
9.3.1.2.3.
By Indication
9.3.1.2.4.
By Treatment Type
9.3.1.2.5.
By Targeted Antigen
9.3.1.2.6.
By End User
9.3.2. Japan CAR-T Cell
Therapy Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product Type
9.3.2.2.2.
By Tumor Type
9.3.2.2.3.
By Indication
9.3.2.2.4.
By Treatment Type
9.3.2.2.5.
By Targeted Antigen
9.3.2.2.6.
By End User
9.3.3. India CAR-T Cell
Therapy Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product Type
9.3.3.2.2.
By Tumor Type
9.3.3.2.3.
By Indication
9.3.3.2.4.
By Treatment Type
9.3.3.2.5.
By Targeted Antigen
9.3.3.2.6.
By End User
9.3.4. Australia Global CAR-T
Cell Therapy Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type